ARCHIVES

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

Cancer Control Emphasis Shift to Prevention Projected For Y 1978; Advisors Seek More

July 29, 1977

DCE Board Ok’s New RFA Programs worth $14 Million

June 29, 1990

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

October 3, 1980

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000